| Authors: |
Gintant G; Department of Integrative Pharmacology, Integrated Sciences and Technology, AbbVie, North Chicago, IL, 60064, USA. Electronic address: gary.gintant@abbvie.com., Kaushik EP; Takeda Pharmaceutical Co, Cambridge, MA, 02139, USA. Electronic address: emily.kaushik@takeda.com., Feaster T; Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, 20993, USA. Electronic address: tromondae.feaster@fda.hhs.gov., Stoelzle-Feix S; Nanion Technologies, Munich, Germany. Electronic address: sonja.stoelzle-feix@nanion.de., Kanda Y; Division of Pharmacology, National Institute of Health Sciences, Kanagawa, Japan. Electronic address: kanda@nihs.go.jp., Osada T; LSI Medience Corporation, Tokyo, Japan. Electronic address: osada.tomoharu@mg.medience.co.jp., Smith G; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK; Clyde Biosciences Ltd., Scotland, UK. Electronic address: godfrey.smith@glasgow.ac.uk., Czysz K; Fujifilm Cellular Dynamics, Inc., Madison, WI, 53711, USA. Electronic address: katherine.czysz@fujifilm.com., Kettenhofen R; Fraunhofer-Institute for Biomed Engineering IBMT, Sulzbach, Germany. Electronic address: ralf.kettenhofen@ibmt.fraunhofer.de., Lu HR; Nonclinical Safety, Johnson & Johnson R&D, Beerse, Belgium. Electronic address: hlu@its.jnj.com., Cai B; Takeda California, Inc., San Diego, CA, 92121, USA. Electronic address: beibei.cai@gmail.com., Shi H; Bristol-Myers Squibb, New York, NY, 10016, USA. Electronic address: hong.shi@bms.com., Herron TJ; Frankel Cardiovascular Regeneration Core Laboratory, University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: toddherr@umich.edu., Dang Q; Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, 20993, USA. Electronic address: qianyu.dang@fda.hhs.gov., Burton F; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK; Clyde Biosciences Ltd., Scotland, UK. Electronic address: francis.burton@glasgow.ac.uk., Pang L; Division of Systems Biology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA. Electronic address: li.pang@fda.hhs.gov., Traebert M; Novartis Inst Biomed Res, Switzerland. Electronic address: martin.traebert@novartis.com., Abassi Y; Agilent Technologies, San Diego, CA, 92121, USA. Electronic address: yama.abassi@agilent.com., Pierson JB; Health and Environmental Sciences Institute, Washington, DC, 20005, USA. Electronic address: jpierson@hesiglobal.org., Blinova K; Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, 20993, USA. Electronic address: ksenia.blinova@fda.hhs.gov. |
